# Rasilez 150 mg · Film-coated tablet · 98



## Belgium

- **FAMHP** — [be.dose-10060.org](https://be.dose-10060.org)

## Codes

- **be-cti-extended** — `303177-01`
- **be-cnk** — `2473262`
- **be-cnk** — `0788554`
- **be-authorisation** — `EU/1/07/405/009`
- **eu-number** — `EU/1/07/405/009`

## Status

- **amp_status** — AUTHORIZED
- **ampp_status** — AUTHORIZED
- **commercialised_now** — False
- **lifecycle** — current
- **period_from** — 2018-01-01
- **supply_problem_now** — False
- **read** — 2026-11-15T03:58:09Z

## Holder

- Noden Pharma DAC

## Proof

Record be:presentation:cti:303177-01 version 1, signed ES256 under dosidal-record-1.9dbf5d53.

## Related records in other markets

- [Rasilez](https://dosidal.ai/pack/pl/105163) — PL — same product (EU central number)

A link shows how two records are related. It does not say one product can be used in place of another.

## Contact

Contact: the form at the bottom of https://dosidal.ai/#contact

---
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
Artificial intelligence makes mistakes. Dosidal is an information source, not a recommendation. Read the regulator.
Dosidal is operated by Dosidal AI Corp. Office: 6687 Nelson Avenue, Suite 304, West Vancouver, BC V7W 2B2, Canada.
© 2027 Dosidal AI Corp.
Dosidal · dosidal.ai · Surface 1.0 (2026-11-16)
